OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and anti-proliferative evaluation of 1H-1,2,3-triazole grafted tetrahydro-β-carboline-chalcone/ferrocenylchalcone conjugates in estrogen responsive and triple negative breast cancer cells
Bharvi Sharma, Liang Gu, Ruvesh Pascal Pillay, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 26, pp. 11137-11147
Closed Access | Times Cited: 23

Showing 23 citing articles:

1,2,3‐Triazole hybrids as anticancer agents: A review
Mohammad Mahboob Alam
Archiv der Pharmazie (2021) Vol. 355, Iss. 1
Closed Access | Times Cited: 205

Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds?
Bharvi Sharma, Vipan Kumar
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 23, pp. 16865-16921
Closed Access | Times Cited: 99

Application of triazoles in the structural modification of natural products
Hongyan Guo, Chen Zheng-ai, Qing‐Kun Shen, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1115-1144
Open Access | Times Cited: 70

β-Carboline-based molecular hybrids as anticancer agents: a brief sketch
Jay Prakash Soni, Yogesh Yeole, Nagula Shankaraiah
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 5, pp. 730-750
Open Access | Times Cited: 41

Recent advances in chalcone-triazole hybrids as potential pharmacological agents
Akanksha Bhukal, Vijay Kumar, Lokesh Kumar, et al.
Results in Chemistry (2023) Vol. 6, pp. 101173-101173
Open Access | Times Cited: 15

Therapeutic potential of chalcone-1,2,3-triazole hybrids as anti-tumour agents: a systematic review and SAR studies
Sakshi Priya, Md. Shafiqul Islam, Shivani Kasana, et al.
Future Medicinal Chemistry (2025) Vol. 17, Iss. 4, pp. 449-465
Closed Access

Recent Advances in Bioactive Flavonoid Hybrids Linked by 1,2,3-Triazole Ring Obtained by Click Chemistry
Daniela Pereira, Madalena Pinto, Marta Correia‐da‐Silva, et al.
Molecules (2021) Vol. 27, Iss. 1, pp. 230-230
Open Access | Times Cited: 39

1,2,3-Triazole Derivatives with Anti-breast Cancer Potential
Xinyi Wu, Jun Wang, Shiqi Xia, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1406-1425
Closed Access | Times Cited: 22

Current scenario of chalcone hybrids with antibreast cancer therapeutic applications
Huan Wang, Juanying Zhu, Qianru Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 5
Closed Access | Times Cited: 3

Click Chemistry in Natural Product Modification
Xiang Zhang, Shuning Zhang, Songfeng Zhao, et al.
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 26

Strategic application of CuAAC click chemistry in the modification of natural products for anticancer activity
Zaozao Xiao, Yuang Gu, Hewei Dong, et al.
European Journal of Medicinal Chemistry Reports (2023) Vol. 9, pp. 100113-100113
Open Access | Times Cited: 9

Isatin-indoloquinoxaline click adducts with a potential to overcome platinum-based drug-resistance in ovarian cancer
Shefali Chowdhary, Asif Raza, Preeti Preeti, et al.
Bioorganic Chemistry (2023) Vol. 142, pp. 106953-106953
Closed Access | Times Cited: 7

Ferrocenyl Azoles: Versatile N‐Containing Heterocycles and their Anticancer Activities
Bhavya Deepthi Sadanala, Rajiv Trivedi
The Chemical Record (2024) Vol. 24, Iss. 7
Closed Access | Times Cited: 2

Synthesis and Biological Evaluation of Harmirins, Novel Harmine–Coumarin Hybrids as Potential Anticancer Agents
Kristina Pavić, Maja Beus, Goran Poje, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6490-6490
Open Access | Times Cited: 19

The anti‐breast cancer therapeutic potential of 1,2,3‐triazole‐containing hybrids
Juntao Song, Shuai Zhang, Bo Zhang, et al.
Archiv der Pharmazie (2023) Vol. 357, Iss. 3
Closed Access | Times Cited: 6

Therapeutic significance of molecular hybrids for breast cancer research and treatment
Devendra Singh Negi, Irshad Ahmad
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 218-238
Open Access | Times Cited: 7

Synthesis of novel pyrrolidinyl chalcone derivatives: Spectral properties, energy band-gap tailoring, and amplified spontaneous emission
Amin O. Elzupir, K.H. Ibnaouf
Journal of Molecular Structure (2021) Vol. 1250, pp. 131698-131698
Closed Access | Times Cited: 9

Tetrahydro-β-carboline-naphthalimide hybrids: Synthesis and anti-proliferative evaluation on estrogen-dependent and triple-negative breast cancer cells
Shalini Shalini, Shubham Lata, Sourav Saha, et al.
Journal of Molecular Structure (2022) Vol. 1262, pp. 133053-133053
Closed Access | Times Cited: 6

New triazole-based coordination complexes as antitumor agents against triple negative breast cancer MDA-MB-468 cell line
Youssef Draoui, Smaail Radi, Yousra Bahjou, et al.
RSC Advances (2023) Vol. 13, Iss. 51, pp. 36158-36167
Open Access | Times Cited: 1

Page 1

Scroll to top